ACE2 and COVID-19: It is known that patients with type 2 diabetes have an increased risk of developing severe COVID-19 and according to a previous study (46), these patients have increased levels of angiotensin-converting enzyme-2 (ACE2) the receptor for SARS-CoV-2, which favors the entry of the virus and decreases its clearance.